Thrive Capital Management, LLC

Institutional investor · Portfolio as of Q2 2025

Top Holdings3 positions

Checking export access…
Activity:
OSCR
OSCR

Oscar Health, Inc.

6.3M$136M57.6%$16.40+30.72%
16 qtrssince 2021-Q3
Unchanged
0
CVNA
CVNA

Carvana Co.

226,761$76.4M32.4%$8.10+732.50%
14 qtrssince 2022-Q1
Decreased
0
VMEO
VMEODelisted

VIMEO INC

5.9M$23.6M10.0%——
17 qtrssince 2021-Q2
Unchanged
0
$236.1M
AUM
3
Positions
Q2 2025
Filing
HI rating · 2.0/5
Quarterly 13F Value Change
Reported 13F value ($M)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2021-Q4$805,652,000-36.6769656894%
2022-Q1$740,576,000-8.07743293631%
2022-Q2$342,270,000-53.7832713996%
2022-Q3$293,647,000-14.2060361703%
2022-Q4$220,535,810-24.8976458128%
2023-Q3$390,494,67477.0663340344%
Activity profile
$ moved · Q2'25
New0%Increased0%Decreased100%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.7 years
<1Q0%1-4Q0%1-2Y0%2Y+100%

Thrive Capital Management, LLC manages $236.1M across 3 positions as of Q2 2025. Top holdings: OSCR (57.6%), CVNA (32.4%), VMEO (10.0%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2/5.0.

Q2 2025 Summary

Exited AMPL; trimmed 1, led by CVNA (−2M shares). No standout high-conviction moves this quarter. Portfolio: $236M across 3 positions.

Portfolio Allocation

Top holdings by portfolio weight

Total AUM$236M
OSCR57.62%
CVNA32.37%
VMEO10.02%
AMPL0.00%
Sector Breakdown

Portfolio allocation by GICS sector

Sectors3
Healthcare57.61%
Consumer Cyclical32.37%
Unknown10.02%
Fund DNA

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Healthcare, Consumer Cyclical, Unknown
Compare DNA across all funds
HoldingsIntel Score
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L53
Conviction67
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Egerton Capital (UK) LLPEgerton Capital (UK) LLP
$9.8B
UEUnisphere Establishment
$11.7B
Checking access…

Explore More

Compare Thrive Capital Managem…
Side-by-side holdings comparison
High-Conviction Picks
Top conviction positions this quarter
Double-Down Detection
Buying into price weakness
Best Trades
Top performing positions by P&L
All High Conviction Activist Funds
Investing archetypes and behavior

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Continue exploring

Explore high-conviction positions
See which stocks have the strongest institutional commitment
Compare with similar funds
Find portfolio overlap with Thrive Capital Management…
Clone this fund
Backtest what copying Thrive Capital Management…'s portfolio would return

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used